FunPep（4881）株式概要ファンペップ株式会社は、医薬品、機能性化粧品、医療機器の研究開発を国内外で行っている。 詳細4881 ファンダメンタル分析スノーフレーク・スコア評価2/6将来の成長0/6過去の実績0/6財務の健全性6/6配当金0/6リスク分析収益が 100 万ドル未満 ( ¥0 )過去5年間で収益は年間23.8%減少しました。 JP市場と比較して、過去 3 か月間の株価の変動が非常に大きい意味のある時価総額がありません ( ¥3B )+1 さらなるリスクすべてのリスクチェックを見る4881 Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair ValueJP¥Current PriceJP¥62.00該当なし内在価値ディスカウントEst. Revenue$PastFuture-2b6m2016201920222025202620282031Revenue JP¥1.0Earnings JP¥0.2AdvancedSet Fair ValueView all narrativesFunPep Company Limited 競合他社Perseus ProteomicsSymbol: TSE:4882Market cap: JP¥2.6bDelta-Fly PharmaSymbol: TSE:4598Market cap: JP¥2.0bKringle PharmaSymbol: TSE:4884Market cap: JP¥3.2bNPTLtdSymbol: TSE:311AMarket cap: JP¥3.4b価格と性能株価の高値、安値、推移の概要FunPep過去の株価現在の株価JP¥62.0052週高値JP¥130.0052週安値JP¥60.00ベータ0.861ヶ月の変化-18.42%3ヶ月変化-33.33%1年変化-40.38%3年間の変化-64.57%5年間の変化-86.86%IPOからの変化-92.05%最新ニュースお知らせ • Mar 11FunPep Company Limited announced that it has received ¥32.5315 million in funding from Next Growth Co., Ltd., Growth Capital, Inc.On March 9, 2026. FunPep Company Limited announces that it has closed the transaction.お知らせ • Feb 12FunPep Company Limited, Annual General Meeting, Mar 26, 2026FunPep Company Limited, Annual General Meeting, Mar 26, 2026.New Risk • Feb 06New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Japanese stocks, typically moving 5.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Revenue has declined by 0% over the past year. Revenue is less than US$1m (JP¥3.0m revenue, or US$19k). Minor Risks Share price has been volatile over the past 3 months (5.6% average weekly change). Shareholders have been diluted in the past year (25% increase in shares outstanding). Market cap is less than US$100m (JP¥3.69b market cap, or US$23.5m).お知らせ • Jan 06FunPep Company Limited to Report Fiscal Year 2025 Results on Feb 12, 2026FunPep Company Limited announced that they will report fiscal year 2025 results on Feb 12, 2026分析記事 • Dec 17Is FunPep (TSE:4881) In A Good Position To Deliver On Growth Plans?We can readily understand why investors are attracted to unprofitable companies. For example, although...お知らせ • Oct 10FunPep Company Limited to Report Q3, 2025 Results on Nov 14, 2025FunPep Company Limited announced that they will report Q3, 2025 results on Nov 14, 2025最新情報をもっと見るRecent updatesお知らせ • Mar 11FunPep Company Limited announced that it has received ¥32.5315 million in funding from Next Growth Co., Ltd., Growth Capital, Inc.On March 9, 2026. FunPep Company Limited announces that it has closed the transaction.お知らせ • Feb 12FunPep Company Limited, Annual General Meeting, Mar 26, 2026FunPep Company Limited, Annual General Meeting, Mar 26, 2026.New Risk • Feb 06New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Japanese stocks, typically moving 5.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Revenue has declined by 0% over the past year. Revenue is less than US$1m (JP¥3.0m revenue, or US$19k). Minor Risks Share price has been volatile over the past 3 months (5.6% average weekly change). Shareholders have been diluted in the past year (25% increase in shares outstanding). Market cap is less than US$100m (JP¥3.69b market cap, or US$23.5m).お知らせ • Jan 06FunPep Company Limited to Report Fiscal Year 2025 Results on Feb 12, 2026FunPep Company Limited announced that they will report fiscal year 2025 results on Feb 12, 2026分析記事 • Dec 17Is FunPep (TSE:4881) In A Good Position To Deliver On Growth Plans?We can readily understand why investors are attracted to unprofitable companies. For example, although...お知らせ • Oct 10FunPep Company Limited to Report Q3, 2025 Results on Nov 14, 2025FunPep Company Limited announced that they will report Q3, 2025 results on Nov 14, 2025New Risk • Aug 25New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 44% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Shareholders have been substantially diluted in the past year (44% increase in shares outstanding). Revenue is less than US$1m (JP¥6.0m revenue, or US$41k). Minor Risk Market cap is less than US$100m (JP¥4.75b market cap, or US$32.2m).お知らせ • Jun 27FunPep Company Limited to Report Q2, 2025 Results on Aug 14, 2025FunPep Company Limited announced that they will report Q2, 2025 results on Aug 14, 2025分析記事 • May 20We're Hopeful That FunPep (TSE:4881) Will Use Its Cash WiselyJust because a business does not make any money, does not mean that the stock will go down. For example, although...New Risk • May 14New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 34% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Shareholders have been substantially diluted in the past year (34% increase in shares outstanding). Revenue is less than US$1m (JP¥6.0m revenue, or US$41k). Minor Risks Share price has been volatile over the past 3 months (8.5% average weekly change). Market cap is less than US$100m (JP¥3.47b market cap, or US$23.6m).お知らせ • Apr 09FunPep Company Limited to Report Q1, 2025 Results on May 14, 2025FunPep Company Limited announced that they will report Q1, 2025 results on May 14, 2025お知らせ • Mar 10FunPep Company Limited announced that it has received ¥3.6 million in funding from SBI Securities Co., Ltd.On March 10,2025, the company has closed the transaction.お知らせ • Feb 12FunPep Company Limited, Annual General Meeting, Mar 27, 2025FunPep Company Limited, Annual General Meeting, Mar 27, 2025.New Risk • Jan 16New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 34% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Shareholders have been substantially diluted in the past year (34% increase in shares outstanding). Revenue is less than US$1m (JP¥3.0m revenue, or US$19k). Minor Risk Market cap is less than US$100m (JP¥4.34b market cap, or US$27.8m).お知らせ • Jan 03FunPep Company Limited to Report Fiscal Year 2024 Results on Feb 12, 2025FunPep Company Limited announced that they will report fiscal year 2024 results on Feb 12, 2025分析記事 • Nov 21Companies Like FunPep (TSE:4881) Are In A Position To Invest In GrowthThere's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...お知らせ • Sep 13FunPep Company Limited to Report Q3, 2024 Results on Nov 14, 2024FunPep Company Limited announced that they will report Q3, 2024 results on Nov 14, 2024お知らせ • Jun 27FunPep Company Limited to Report Q2, 2024 Results on Aug 08, 2024FunPep Company Limited announced that they will report Q2, 2024 results on Aug 08, 2024分析記事 • Jun 10Is FunPep (TSE:4881) In A Good Position To Deliver On Growth Plans?We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...お知らせ • Apr 10FunPep Company Limited to Report Q1, 2024 Results on May 13, 2024FunPep Company Limited announced that they will report Q1, 2024 results on May 13, 2024お知らせ • Mar 21FunPep Company Limited announced that it has received ¥199.9998 million in funding from Shionogi & Co., Ltd.On March 21, 2024, FunPep Company Limited closed the transaction.New Risk • Mar 05New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Japanese stocks, typically moving 13% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (13% average weekly change). Revenue has declined by 100% over the past year. Revenue is less than US$1m. Minor Risks Less than 3 years of financial data is available. Shareholders have been diluted in the past year (13% increase in shares outstanding). Market cap is less than US$100m (JP¥4.24b market cap, or US$28.2m).お知らせ • Mar 04FunPep Company Limited announced that it expects to receive ¥199.9998 million in funding from Shionogi & Co., Ltd.FunPep Company Limited announced that it has entered into an option agreement with returning investor Shionogi & Co., Ltd. who holds holding 1,095,200 shares to issue 1,587,300 common shares at an issue price of ¥126 per share for the gross proceeds of ¥197,499,800 on March 4, 2024. The transaction has been approved by the shareholders of the company and is expected to close on March 21, 2024. The company has disclosed the issue expenses of ¥2,500,000 and the net proceeds of ¥197,499,800.お知らせ • Feb 16FunPep Company Limited, Annual General Meeting, Mar 27, 2024FunPep Company Limited, Annual General Meeting, Mar 27, 2024.お知らせ • Feb 07FunPep Company Limited to Report Fiscal Year 2023 Results on Feb 14, 2024FunPep Company Limited announced that they will report fiscal year 2023 results on Feb 14, 2024お知らせ • Oct 05FunPep Company Limited to Report Q3, 2023 Results on Nov 14, 2023FunPep Company Limited announced that they will report Q3, 2023 results on Nov 14, 2023お知らせ • May 28FunPep Company Limited to Report Q2, 2023 Results on Aug 14, 2023FunPep Company Limited announced that they will report Q2, 2023 results on Aug 14, 2023Reported Earnings • Feb 16Full year 2022 earnings released: JP¥61.01 loss per share (vs JP¥39.56 loss in FY 2021)Full year 2022 results: JP¥61.01 loss per share (further deteriorated from JP¥39.56 loss in FY 2021). Net loss: JP¥1.17b (loss widened 72% from FY 2021).お知らせ • Dec 06FunPep Company Limited to Report Fiscal Year 2022 Results on Feb 14, 2023FunPep Company Limited announced that they will report fiscal year 2022 results on Feb 14, 2023Board Change • Nov 16No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 6 non-independent directors. Director Tsutomu Une was the last director to join the board, commencing their role in 2022. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.お知らせ • Aug 28FunPep Company Limited to Report Q3, 2022 Results on Nov 14, 2022FunPep Company Limited announced that they will report Q3, 2022 results on Nov 14, 2022お知らせ • Jul 16FunPep Company Limited (TSE:4881) agreed to acquire Anti-Aging Peptide.FunPep Company Limited (TSE:4881) agreed to acquire Anti-Aging Peptide Co., Ltd. from Hironori Nakagami , Bio Site Start Fund L.P., Naotaka Hashiya, Chiyako Ueda, ReBeage Co., Ltd. and others on July 14, 2022. As per the teams of the deal 6,500 shares of the FunPep Company Limited will be allotted and delivered for each Anti-Aging Peptide share. Anti-Aging Peptide Co., Ltd. reported Net worth of JPY68 million, Total assets of JPY68 million, Operating loss(EBIT) of JPY1 million and Net loss of JPY 3 million for the year ended December 31, 2021. Deal is subject to subject to approval at the extraordinary general meeting of shareholders. Share Exchange is expected to be effective on October 1, 2022.お知らせ • Jun 29FunPep Company Limited to Report Q2, 2022 Results on Aug 12, 2022FunPep Company Limited announced that they will report Q2, 2022 results on Aug 12, 2022Board Change • Apr 27No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 6 non-independent directors. Director Tsutomu Une was the last director to join the board, commencing their role in 2022. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.お知らせ • Apr 10FunPep Company Limited to Report Q1, 2022 Results on May 13, 2022FunPep Company Limited announced that they will report Q1, 2022 results on May 13, 2022お知らせ • Feb 17FunPep Company Limited, Annual General Meeting, Mar 29, 2022FunPep Company Limited, Annual General Meeting, Mar 29, 2022.お知らせ • Dec 14FunPep Company Limited announced that it has received ¥3.741 million in funding from SBI Securities Co., Ltd., Investment ArmON December 13, 2021, FunPep Company Limited closed the transaction.お知らせ • Nov 27FunPep Company Limited announced that it expects to receive ¥3.741 million in funding from SBI Securities Co., Ltd., Investment ArmFunPep Company Limited announced a third-party allotment agreement for a private placement of 43,000 units of the 9th stock acquisition rights at an issue price of ¥87 per stock acquisition right for gross proceeds of ¥3,741,000 on November 26 2021. The transaction will involve participation from SBI Securities Co., Ltd., Investment Arm. The stock acquisition right may be converted into 4,300,000 shares (100 shares per stock acquisition right), with initial exercise price of ¥297 per share. The company will pay issuance expenses, including attorney's fees, valuation calculation costs, trust bank costs, etc. of ¥12,000,000. The period during which the stock acquisition rights can be exercised from December 14, 2021 to December 13, 2023. The allotment date is December 13, 2021. The transaction is approved by the board of directors of the companyReported Earnings • Apr 01Full year 2020 earnings released: JP¥40.30 loss per share (vs JP¥20.23 loss in FY 2019)Full year 2020 results: Net loss: JP¥507.0m (loss widened 116% from FY 2019).Reported Earnings • Feb 14Full year 2020 earnings released: JP¥40.30 loss per share (vs JP¥20.23 loss in FY 2019)Full year 2020 results: Net loss: JP¥507.0m (loss widened 116% from FY 2019).お知らせ • Feb 12FunPep Company Limited, Annual General Meeting, Mar 25, 2021FunPep Company Limited, Annual General Meeting, Mar 25, 2021.株主還元4881JP BiotechsJP 市場7D-4.6%-6.8%-0.5%1Y-40.4%-12.9%41.3%株主還元を見る業界別リターン: 4881過去 1 年間で-12.9 % の収益を上げたJP Biotechs業界を下回りました。リターン対市場: 4881は、過去 1 年間で41.3 % のリターンを上げたJP市場を下回りました。価格変動Is 4881's price volatile compared to industry and market?4881 volatility4881 Average Weekly Movement14.6%Biotechs Industry Average Movement9.4%Market Average Movement5.0%10% most volatile stocks in JP Market9.7%10% least volatile stocks in JP Market2.5%安定した株価: 4881の株価は、 JP市場と比較して過去 3 か月間で変動しています。時間の経過による変動: 4881の 週次ボラティリティ は、過去 1 年間で9%から15%に増加しました。会社概要設立従業員CEO（最高経営責任者ウェブサイト201315Toshimi Miyoshiwww.funpep.co.jp株式会社ファンペップは、医薬品、機能性化粧品、医療機器の研究開発を国内外で行っている。皮膚潰瘍治療薬として臨床第III相試験中の機能性ペプチドSR-0379、乾癬・強直性脊椎炎治療薬として臨床第II相試験中の抗体誘導ペプチドFPP003、花粉症治療薬として臨床第I相試験中の抗体誘導ペプチドFPP004X、乾癬治療薬として前臨床試験中の抗体誘導ペプチドFPP005を開発。また、細菌の細胞膜を破壊する抗菌ペプチド、キュアペプチンの開発にも携わっている。同社は2013年に設立され、茨城県に本社を置いている。もっと見るFunPep Company Limited 基礎のまとめFunPep の収益と売上を時価総額と比較するとどうか。4881 基礎統計学時価総額JP¥2.54b収益（TTM）-JP¥1.60b売上高(TTM)n/a0.0xP/Sレシオ-1.6xPER（株価収益率4881 は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計4881 損益計算書（TTM）収益JP¥0売上原価JP¥0売上総利益JP¥0その他の費用JP¥1.60b収益-JP¥1.60b直近の収益報告Mar 31, 2026次回決算日該当なし一株当たり利益（EPS）-39.20グロス・マージン0.00%純利益率0.00%有利子負債／自己資本比率0%4881 の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/22 18:02終値2026/05/22 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋FunPep Company Limited 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • Mar 11FunPep Company Limited announced that it has received ¥32.5315 million in funding from Next Growth Co., Ltd., Growth Capital, Inc.On March 9, 2026. FunPep Company Limited announces that it has closed the transaction.
お知らせ • Feb 12FunPep Company Limited, Annual General Meeting, Mar 26, 2026FunPep Company Limited, Annual General Meeting, Mar 26, 2026.
New Risk • Feb 06New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Japanese stocks, typically moving 5.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Revenue has declined by 0% over the past year. Revenue is less than US$1m (JP¥3.0m revenue, or US$19k). Minor Risks Share price has been volatile over the past 3 months (5.6% average weekly change). Shareholders have been diluted in the past year (25% increase in shares outstanding). Market cap is less than US$100m (JP¥3.69b market cap, or US$23.5m).
お知らせ • Jan 06FunPep Company Limited to Report Fiscal Year 2025 Results on Feb 12, 2026FunPep Company Limited announced that they will report fiscal year 2025 results on Feb 12, 2026
分析記事 • Dec 17Is FunPep (TSE:4881) In A Good Position To Deliver On Growth Plans?We can readily understand why investors are attracted to unprofitable companies. For example, although...
お知らせ • Oct 10FunPep Company Limited to Report Q3, 2025 Results on Nov 14, 2025FunPep Company Limited announced that they will report Q3, 2025 results on Nov 14, 2025
お知らせ • Mar 11FunPep Company Limited announced that it has received ¥32.5315 million in funding from Next Growth Co., Ltd., Growth Capital, Inc.On March 9, 2026. FunPep Company Limited announces that it has closed the transaction.
お知らせ • Feb 12FunPep Company Limited, Annual General Meeting, Mar 26, 2026FunPep Company Limited, Annual General Meeting, Mar 26, 2026.
New Risk • Feb 06New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Japanese stocks, typically moving 5.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Revenue has declined by 0% over the past year. Revenue is less than US$1m (JP¥3.0m revenue, or US$19k). Minor Risks Share price has been volatile over the past 3 months (5.6% average weekly change). Shareholders have been diluted in the past year (25% increase in shares outstanding). Market cap is less than US$100m (JP¥3.69b market cap, or US$23.5m).
お知らせ • Jan 06FunPep Company Limited to Report Fiscal Year 2025 Results on Feb 12, 2026FunPep Company Limited announced that they will report fiscal year 2025 results on Feb 12, 2026
分析記事 • Dec 17Is FunPep (TSE:4881) In A Good Position To Deliver On Growth Plans?We can readily understand why investors are attracted to unprofitable companies. For example, although...
お知らせ • Oct 10FunPep Company Limited to Report Q3, 2025 Results on Nov 14, 2025FunPep Company Limited announced that they will report Q3, 2025 results on Nov 14, 2025
New Risk • Aug 25New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 44% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Shareholders have been substantially diluted in the past year (44% increase in shares outstanding). Revenue is less than US$1m (JP¥6.0m revenue, or US$41k). Minor Risk Market cap is less than US$100m (JP¥4.75b market cap, or US$32.2m).
お知らせ • Jun 27FunPep Company Limited to Report Q2, 2025 Results on Aug 14, 2025FunPep Company Limited announced that they will report Q2, 2025 results on Aug 14, 2025
分析記事 • May 20We're Hopeful That FunPep (TSE:4881) Will Use Its Cash WiselyJust because a business does not make any money, does not mean that the stock will go down. For example, although...
New Risk • May 14New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 34% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Shareholders have been substantially diluted in the past year (34% increase in shares outstanding). Revenue is less than US$1m (JP¥6.0m revenue, or US$41k). Minor Risks Share price has been volatile over the past 3 months (8.5% average weekly change). Market cap is less than US$100m (JP¥3.47b market cap, or US$23.6m).
お知らせ • Apr 09FunPep Company Limited to Report Q1, 2025 Results on May 14, 2025FunPep Company Limited announced that they will report Q1, 2025 results on May 14, 2025
お知らせ • Mar 10FunPep Company Limited announced that it has received ¥3.6 million in funding from SBI Securities Co., Ltd.On March 10,2025, the company has closed the transaction.
お知らせ • Feb 12FunPep Company Limited, Annual General Meeting, Mar 27, 2025FunPep Company Limited, Annual General Meeting, Mar 27, 2025.
New Risk • Jan 16New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 34% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Shareholders have been substantially diluted in the past year (34% increase in shares outstanding). Revenue is less than US$1m (JP¥3.0m revenue, or US$19k). Minor Risk Market cap is less than US$100m (JP¥4.34b market cap, or US$27.8m).
お知らせ • Jan 03FunPep Company Limited to Report Fiscal Year 2024 Results on Feb 12, 2025FunPep Company Limited announced that they will report fiscal year 2024 results on Feb 12, 2025
分析記事 • Nov 21Companies Like FunPep (TSE:4881) Are In A Position To Invest In GrowthThere's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...
お知らせ • Sep 13FunPep Company Limited to Report Q3, 2024 Results on Nov 14, 2024FunPep Company Limited announced that they will report Q3, 2024 results on Nov 14, 2024
お知らせ • Jun 27FunPep Company Limited to Report Q2, 2024 Results on Aug 08, 2024FunPep Company Limited announced that they will report Q2, 2024 results on Aug 08, 2024
分析記事 • Jun 10Is FunPep (TSE:4881) In A Good Position To Deliver On Growth Plans?We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...
お知らせ • Apr 10FunPep Company Limited to Report Q1, 2024 Results on May 13, 2024FunPep Company Limited announced that they will report Q1, 2024 results on May 13, 2024
お知らせ • Mar 21FunPep Company Limited announced that it has received ¥199.9998 million in funding from Shionogi & Co., Ltd.On March 21, 2024, FunPep Company Limited closed the transaction.
New Risk • Mar 05New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Japanese stocks, typically moving 13% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (13% average weekly change). Revenue has declined by 100% over the past year. Revenue is less than US$1m. Minor Risks Less than 3 years of financial data is available. Shareholders have been diluted in the past year (13% increase in shares outstanding). Market cap is less than US$100m (JP¥4.24b market cap, or US$28.2m).
お知らせ • Mar 04FunPep Company Limited announced that it expects to receive ¥199.9998 million in funding from Shionogi & Co., Ltd.FunPep Company Limited announced that it has entered into an option agreement with returning investor Shionogi & Co., Ltd. who holds holding 1,095,200 shares to issue 1,587,300 common shares at an issue price of ¥126 per share for the gross proceeds of ¥197,499,800 on March 4, 2024. The transaction has been approved by the shareholders of the company and is expected to close on March 21, 2024. The company has disclosed the issue expenses of ¥2,500,000 and the net proceeds of ¥197,499,800.
お知らせ • Feb 16FunPep Company Limited, Annual General Meeting, Mar 27, 2024FunPep Company Limited, Annual General Meeting, Mar 27, 2024.
お知らせ • Feb 07FunPep Company Limited to Report Fiscal Year 2023 Results on Feb 14, 2024FunPep Company Limited announced that they will report fiscal year 2023 results on Feb 14, 2024
お知らせ • Oct 05FunPep Company Limited to Report Q3, 2023 Results on Nov 14, 2023FunPep Company Limited announced that they will report Q3, 2023 results on Nov 14, 2023
お知らせ • May 28FunPep Company Limited to Report Q2, 2023 Results on Aug 14, 2023FunPep Company Limited announced that they will report Q2, 2023 results on Aug 14, 2023
Reported Earnings • Feb 16Full year 2022 earnings released: JP¥61.01 loss per share (vs JP¥39.56 loss in FY 2021)Full year 2022 results: JP¥61.01 loss per share (further deteriorated from JP¥39.56 loss in FY 2021). Net loss: JP¥1.17b (loss widened 72% from FY 2021).
お知らせ • Dec 06FunPep Company Limited to Report Fiscal Year 2022 Results on Feb 14, 2023FunPep Company Limited announced that they will report fiscal year 2022 results on Feb 14, 2023
Board Change • Nov 16No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 6 non-independent directors. Director Tsutomu Une was the last director to join the board, commencing their role in 2022. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
お知らせ • Aug 28FunPep Company Limited to Report Q3, 2022 Results on Nov 14, 2022FunPep Company Limited announced that they will report Q3, 2022 results on Nov 14, 2022
お知らせ • Jul 16FunPep Company Limited (TSE:4881) agreed to acquire Anti-Aging Peptide.FunPep Company Limited (TSE:4881) agreed to acquire Anti-Aging Peptide Co., Ltd. from Hironori Nakagami , Bio Site Start Fund L.P., Naotaka Hashiya, Chiyako Ueda, ReBeage Co., Ltd. and others on July 14, 2022. As per the teams of the deal 6,500 shares of the FunPep Company Limited will be allotted and delivered for each Anti-Aging Peptide share. Anti-Aging Peptide Co., Ltd. reported Net worth of JPY68 million, Total assets of JPY68 million, Operating loss(EBIT) of JPY1 million and Net loss of JPY 3 million for the year ended December 31, 2021. Deal is subject to subject to approval at the extraordinary general meeting of shareholders. Share Exchange is expected to be effective on October 1, 2022.
お知らせ • Jun 29FunPep Company Limited to Report Q2, 2022 Results on Aug 12, 2022FunPep Company Limited announced that they will report Q2, 2022 results on Aug 12, 2022
Board Change • Apr 27No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 6 non-independent directors. Director Tsutomu Une was the last director to join the board, commencing their role in 2022. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
お知らせ • Apr 10FunPep Company Limited to Report Q1, 2022 Results on May 13, 2022FunPep Company Limited announced that they will report Q1, 2022 results on May 13, 2022
お知らせ • Feb 17FunPep Company Limited, Annual General Meeting, Mar 29, 2022FunPep Company Limited, Annual General Meeting, Mar 29, 2022.
お知らせ • Dec 14FunPep Company Limited announced that it has received ¥3.741 million in funding from SBI Securities Co., Ltd., Investment ArmON December 13, 2021, FunPep Company Limited closed the transaction.
お知らせ • Nov 27FunPep Company Limited announced that it expects to receive ¥3.741 million in funding from SBI Securities Co., Ltd., Investment ArmFunPep Company Limited announced a third-party allotment agreement for a private placement of 43,000 units of the 9th stock acquisition rights at an issue price of ¥87 per stock acquisition right for gross proceeds of ¥3,741,000 on November 26 2021. The transaction will involve participation from SBI Securities Co., Ltd., Investment Arm. The stock acquisition right may be converted into 4,300,000 shares (100 shares per stock acquisition right), with initial exercise price of ¥297 per share. The company will pay issuance expenses, including attorney's fees, valuation calculation costs, trust bank costs, etc. of ¥12,000,000. The period during which the stock acquisition rights can be exercised from December 14, 2021 to December 13, 2023. The allotment date is December 13, 2021. The transaction is approved by the board of directors of the company
Reported Earnings • Apr 01Full year 2020 earnings released: JP¥40.30 loss per share (vs JP¥20.23 loss in FY 2019)Full year 2020 results: Net loss: JP¥507.0m (loss widened 116% from FY 2019).
Reported Earnings • Feb 14Full year 2020 earnings released: JP¥40.30 loss per share (vs JP¥20.23 loss in FY 2019)Full year 2020 results: Net loss: JP¥507.0m (loss widened 116% from FY 2019).
お知らせ • Feb 12FunPep Company Limited, Annual General Meeting, Mar 25, 2021FunPep Company Limited, Annual General Meeting, Mar 25, 2021.
